Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKU

Akumin (AKU) Stock Price, News & Analysis

Akumin logo

About Akumin Stock (NASDAQ:AKU)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.13
$0.36
52-Week Range
N/A
Volume
8.54 million shs
Average Volume
1.38 million shs
Market Capitalization
$26.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Receive AKU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

AKU Stock News Headlines

Broward radiology firm names CEO
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Elon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.
Adcore: Top 10 Undervalued Growth Stocks on TSX (ADCO)
See More Headlines

AKU Stock Analysis - Frequently Asked Questions

Akumin Inc. (NASDAQ:AKU) released its earnings results on Monday, December, 13th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.43) by $0.41. The firm earned $108.18 million during the quarter, compared to analysts' expectations of $109.25 million. Akumin had a negative trailing twelve-month return on equity of 167.86% and a negative net margin of 30.56%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akumin investors own include Labor Smart (LTNC), NVIDIA (NVDA), Processa Pharmaceuticals (PCSA), Acrivon Therapeutics (ACRV), Canopy Growth (CGC), Aeva Technologies (AEVA) and AST SpaceMobile (ASTS).

Company Calendar

Last Earnings
12/13/2021
Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:AKU
Fax
N/A
Employees
3,631
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-156,760,000.00
Pretax Margin
-28.78%

Debt

Sales & Book Value

Annual Sales
$749.63 million
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
N/A

Miscellaneous

Free Float
72,473,000
Market Cap
$26.32 million
Optionable
Not Optionable
Beta
-0.72
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:AKU) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners